查詢結果分析
相關文獻
- Evaluation of Buffering Capacity and Acid Neutralizing-pH Time Profile of Antacids
- Therapeutic Effects of Low-Doses Acid-Reducing Agents in Patients with Duodenal Ulcer
- 消化道疾病探討及制酸劑(Antacid)的臨床應用
- 「胃藥」--制酸劑的合理使用
- Quinolone藥物與制酸劑之交互作用
- Prophylaxis Against Acid Aspiration in Regional Anesthesia for Elective Cesarean Section: A Comparison between Oral Single-Dose Ranitidine, Famotidine and Omeprazole Assessed with Fiberoptic Gastric Aspiration
- Non-Steroidal Anti-Inflammatory Drug and Antacid Co-Prescription in Taiwan: Analysis of National Insurance Claims
- 細胞色素P450 2C19基因多形性與胃酸相關疾病治療之關係
- 胃藥及制酸劑
- 從實證醫學觀點探討制酸劑用於上腹痛
頁籤選單縮合
題 名 | Evaluation of Buffering Capacity and Acid Neutralizing-pH Time Profile of Antacids=制酸劑之緩衝能力及酸中和能力評估 |
---|---|
作 者 | 林美淑; 孫斌; 余秀英; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 97:10 1998.10[民87.10] |
頁 次 | 頁704-710 |
分類號 | 418.244 |
關鍵詞 | 制酸劑; Antacid; Buffering capacity; pH; Neutralization; |
語 文 | 英文(English) |
英文摘要 | The antacid properties of seven antacids listed in the hospital formulary of a medical center were evaluated with in vitro tests. These included not noly the preliminary antacid test and acid-neutralizing capacity test as described in the United States Pharmacopeia (USP XXⅢ), but also a buffering pH profile test. The preliminary antacid test measured the final pH of a 10-mL solution of 0.5 N HCI 10 minutes after addition of the minimum recommended dose of an antacid, while the neutralizing capacity test measured the amount (mEq) of HCI neutralized by the minimum recommended dose in 15 minutes. The buffering pH profile recorded the pH time course of dynamic simulated gastric fluid neutralization by a dose of an antacid. In the preliminary antacid test, magnesium oxide showed the highest pH (9.52±0.14,mean±standard deviation, n=3) ;aluminum phosphate gel yielded a final pH of 2.51±0.01, thus failing to meet the criteria of an antacid (pH>3.5). In the acidneutralizing capacity test, hydrotalcite had the highest neutralizing capacity (28.26±0.3 mEq), while sodium bicarbonate had the lowest (7.40±0.12 mEq). In the buffering pH profile test, aluminum-magnesium hydroxide suspensions and hydrotalcite tablets maintained a steady optimum pH (3-5) for around 1.5 horus. One tablet of calcium carbonate, sodium bicarbonate or magnesium oxide could not raise the gastric pH to above 3, but two tablets increased the pH excessively (5.3 to 8.6). The higher dose (two tablets) of aluminum hydroxide hexitol complex could not raise the pH to the optimal leval. These findings demonstrate that there is disparity in the antacid effectiveness estimated by the neutralizing capacity test and the buffering pH profile test and suggest that the efficacy of an antacid cannot be accurately predicted from its acid-neutralizing capacity. The dose of antacids greatly influences the neutralizing pH profiles. Aluminum-magnesium compounds appear to provide steadier buffering than carbonate compounds or magnesium oxide. |
本系統中英文摘要資訊取自各篇刊載內容。